Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts

Healthcare giant Johnson & Johnson (JNJ - ) on Tuesday reported first-quarter earnings that were lower than last year though still beat analysts' expectations, even as it faces litigation over allegations that its iconic talc baby powder contained asbestos, and it battles increased competition from generic prostate cancer drugs.